BRAINSTORM CELL THERAPEUTICS INC. Quarterly Operating Income (Loss) in USD from Q3 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Brainstorm Cell Therapeutics Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2010 to Q4 2024.
  • Brainstorm Cell Therapeutics Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$3.19M, a 33.6% increase year-over-year.
  • Brainstorm Cell Therapeutics Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$11.7M, a 45.5% increase year-over-year.
  • Brainstorm Cell Therapeutics Inc. annual Operating Income (Loss) for 2024 was -$11.7M, a 45.5% increase from 2023.
  • Brainstorm Cell Therapeutics Inc. annual Operating Income (Loss) for 2023 was -$21.4M, a 13.6% increase from 2022.
  • Brainstorm Cell Therapeutics Inc. annual Operating Income (Loss) for 2022 was -$24.8M, a 1.15% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$11.7M -$3.19M +$1.62M +33.6% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-31
Q3 2024 -$13.3M -$3.05M +$2.99M +49.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$16.3M -$2.98M +$2.47M +45.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$18.8M -$2.47M +$2.68M +52% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$21.4M -$4.8M +$111K +2.26% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-31
Q3 2023 -$21.6M -$6.04M +$806K +11.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$22.4M -$5.45M +$2.14M +28.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$24.5M -$5.15M +$324K +5.92% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$24.8M -$4.92M +$1.3M +20.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$26.1M -$6.84M -$1.56M -29.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$24.6M -$7.59M -$1.47M -24% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$23.1M -$5.48M +$1.45M +21% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$24.5M -$6.21M +$5.28M +45.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$29.8M -$5.28M -$792K -17.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$29M -$6.12M +$1.28M +17.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$30.3M -$6.93M +$1.38M +16.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$31.7M -$11.5M -$3.83M -49.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 -$27.9M -$4.49M +$1.07M +19.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$28.9M -$7.4M -$2.54M -52.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$26.4M -$8.31M -$3.38M -68.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-26
Q4 2019 -$23M -$7.67M -$2.23M -41% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-04
Q3 2019 -$20.8M -$5.55M -$2.32M -71.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-15
Q2 2019 -$18.5M -$4.86M -$1.77M -57.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 -$16.7M -$4.93M -$2.62M -114% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$14.1M -$5.44M -$5.68M -2384% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-18
Q3 2018 -$8.39M -$3.23M -$840K -35.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$7.55M -$3.09M -$2.01M -187% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$5.54M -$2.31M -$537K -30.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$5M $238K +$888K Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 -$5.89M -$2.39M -$754K -46% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-29
Q2 2017 -$5.13M -$1.08M -$92K -9.36% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-23
Q1 2017 -$5.04M -$1.77M +$42K +2.32% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 -$5.08M -$650K +$747K +53.5% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-08
Q3 2016 -$5.83M -$1.64M +$933K +36.3% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-17
Q2 2016 -$6.76M -$983K +$1.38M +58.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$8.14M -$1.81M +$393K +17.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$8.54M -$1.4M +$189K +11.9% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-29
Q3 2015 -$8.73M -$2.57M -$141K -5.8% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$8.58M -$2.36M -$1.07M -82.6% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$7.52M -$2.21M -$94K -4.45% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$7.42M -$1.59M -$350K -28.3% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-09
Q3 2014 -$7.07M -$2.43M -$1.35M -125% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 -$5.72M -$1.29M +$206K +13.7% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$5.93M -$2.11M -$1.03M -95.1% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 -$4.9M -$1.24M -$658K -114% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-26
Q3 2013 -$4.24M -$1.08M +$69K +6% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 -$4.31M -$1.5M -$671K -80.9% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 -$3.64M -$1.08M -$214K -24.7% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q4 2012 -$3.43M -$578K +$4.44M +88.5% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-27
Q3 2012 -$7.86M -$1.15M -$456K -65.7% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$7.41M -$829K -$1.92M -176% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$5.49M -$868K -$1.57M -223% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$3.91M -$5.02M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-14
Q3 2011 -$694K -$1.37M -202% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 $1.09M Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-08-29
Q1 2011 $705K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-11
Q3 2010 $680K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.